U.S. House Oversight Committee Sends Letter to Mylan (MYL) CEO Bresch; Requests EpiPen Info

August 29, 2016 2:42 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

The U.S. House Committee on Oversight and Government Reform sent a letter to Mylan (NASDAQ: MYL) CEO Heather Bresch today. In part, the letter requests a briefing on EpiPen, as well as certain supporting documents and information.

The letter from Reps Jason Chaffetz and Elijah Cummings is embedded below:

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Litigation, Trader Talk

Add Your Comment